Comparative Effectiveness
Protocol: PROT001
Status: Closed
Eligibility
Each clinical study has its own guidelines for who may participate, called eligibility criteria.
Condition
Stage I-III Breast Cancer,
Stage I-III Non Small Cell Lung Cancer
Additional eligibility requirements:
- Be diagnosed with stage I-III breast cancer or stage I-III non small cell lung cancer
- Currently be in treatment or have completed initial cancer treatments within the past
6 months
- Be experiencing cancer-related symptoms of depression and/or anxiety
- Have a tablet or smartphone
Find out more
Complete this form to inquire about trial enrollment or additional information.
